Your browser doesn't support javascript.
loading
Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α.
DeVoti, James A; Israr, Mohd; Lam, Fung; Papayannakos, Christopher; Frank, Douglas K; Kamdar, Dev P; Pereira, Lucio M; Abramson, Allan; Steinberg, Bettie M; Bonagura, Vincent R.
Afiliación
  • DeVoti JA; Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, United States.
  • Israr M; Department of Pediatrics, Steven and Alexandra Cohen Children's Medical Center of New York, Barbara and Donald Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States.
  • Lam F; Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, United States.
  • Papayannakos C; Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, United States.
  • Frank DK; Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, United States.
  • Kamdar DP; Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, United States.
  • Pereira LM; Department of Otolaryngology, Long Island Jewish Medical Center, Barbara and Donald Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States.
  • Abramson A; Department of Otolaryngology, Long Island Jewish Medical Center, Barbara and Donald Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States.
  • Steinberg BM; Department of Otolaryngology, Long Island Jewish Medical Center, Barbara and Donald Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States.
  • Bonagura VR; Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, United States.
Front Immunol ; 13: 1011772, 2022.
Article en En | MEDLINE | ID: mdl-36426368
ABSTRACT
Oropharyngeal squamous cell cancer (OPC) accounts for 3% of all cancers and greater than 1.5% of all cancer deaths in the United States, with marked treatment-associated morbidity in survivors. More than 80% of OPC is caused by HPV16. Tumors induced by HPV have been linked to impaired immune functions, with most studies focused on the local tumor microenvironment. Fewer studies have characterized the effects of these tumors on systemic responses in OPC, especially innate responses that drive subsequent adaptive responses, potentially creating feed-back loops favorable to the tumor. Here we report that elevated plasma levels of PGE2 are expressed in half of patients with OPC secondary to overexpression of COX-2 by peripheral blood monocytes, and this expression is driven by IL-1α secreted by the tumors. Monocytes from patients are much more sensitive to the stimulation than monocytes from controls, suggesting the possibility of enhanced immune-modulating feed-back loops. Furthermore, control monocytes pre-exposed to PGE2 overexpress COX-2 in response to IL-1α, simulating responses made by monocytes from some OPC patients. Disrupting the PGE2/IL-1α feed-back loop can have potential impact on targeted medical therapies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monocitos / Neoplasias Orofaríngeas / Ciclooxigenasa 2 / Interleucina-1alfa Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monocitos / Neoplasias Orofaríngeas / Ciclooxigenasa 2 / Interleucina-1alfa Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos